日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multicentre, open-label, prospective, parallel-controlled study protocol evaluating the effects of amino acid peritoneal dialysis solution on nutritional status in Chinese peritoneal dialysis patients

一项多中心、开放标签、前瞻性、平行对照研究方案,旨在评估氨基酸腹膜透析液对中国腹膜透析患者营养状况的影响。

Zhou, Jiayue; Jiang, Wenli; Zhang, Xiang; Shi, Jianjian; Ai, Lijuan; Xia, Cong; Lin, Fan; Xiang, Xiaojun; He, Qiang; Chen, Hongbo; Hu, Shouci

Development and clinical trial of M701, an Anti-EpCAM × Anti-CD3 bispecific antibody: a targeted intraperitoneal therapy for malignant ascites stemming from advanced solid tumors

M701(一种抗EpCAM × 抗CD3双特异性抗体)的研发和临床试验:一种针对晚期实体瘤引起的恶性腹水的靶向腹腔内疗法

Liu, Rongrui; Lin, Rongbo; Li, Ning; Li, Guiling; Zhang, Tao; Zhao, Jun; Li, Jiayi; Sun, Meili; Wang, Ke; An, Hanxiang; Zhang, Weijie; Xu, Huiting; Zeng, Shan; Zhang, Mingjun; Duan, Wei; Bai, Yuxian; Zhang, Jingdong; Tian, He; Yin, Fei; Kang, Yu; Xu, Qi; Xu, Nong; Deng, Yanhong; Chen, Qing; Li, Yongqiang; Yang, Hongying; Su, Fang; Xiao, Zhenghong; Xiang, Xiaojun; Zhou, Pengfei; Huang, Shaoyi; Zhang, Jing; Xu, Jianming

Anaplastic Lymphoma Kinase (ALK) Inhibitors Show Activity in Colorectal Cancer With ALK Rearrangements: Case Series and Literature Review

间变性淋巴瘤激酶 (ALK) 抑制剂对伴有 ALK 重排的结直肠癌显示出活性:病例系列和文献综述

Hu, Tingting; Zhan, Jinbo; Li, Li; He, Yan; Lin, Yun; Wang, Jingru; Yu, Haiming; Xiong, Jianping; Fang, Ziling; Deng, Jun; Huang, Shanshan; Xiang, Xiaojun

A multicenter retrospective study of PD-1 blockade plus chemotherapy as first-line therapy in advanced hepatoid adenocarcinoma of the stomach

一项多中心回顾性研究探讨了PD-1阻断联合化疗作为晚期胃肝样腺癌一线治疗的疗效。

Wang, Jingru; Zhan, Jinbo; Rao, Zhen; Su, Gang; He, Yan; Zhou, Ling; Wu, Jianhua; Sun, Xiaowei; Xiang, Xiaojun

SYHA1813, A VEGFR and CSF1R Inhibitor, in Patients With Recurrent High-Grade Gliomas: A Multicenter, Open-Label Phase I Study

SYHA1813(一种 VEGFR 和 CSF1R 抑制剂)治疗复发性高级别胶质瘤患者:一项多中心、开放标签的 I 期研究

Kang, Zhuang; Li, Shenglan; Wang, Liang; Chen, Qianxue; Hu, Weiguo; Lei, Ting; Mao, Ying; Zhang, Jing; Xiang, Xiaojun; Wang, Qiming; He, Zhengwen; Sun, Tao; Wang, Yulei; Huang, Mengqian; Zhang, Rong; Chen, Feng; Li, Wenbin

[Retracted] Ruscogenin induces ferroptosis in pancreatic cancer cells

【已撤稿】假叶树皂苷元诱导胰腺癌细胞发生铁死亡

Song, Zhiwang; Xiang, Xiaojun; Li, Junhe; Deng, Jun; Fang, Ziling; Zhang, Ling; Xiong, Jianping

Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment

释放FGFR抑制剂与免疫检查点阻断联合治疗在肿瘤微环境中FGF/FGFR信号通路中的潜力

Ruan, Ruiwen; Li, Li; Li, Xuan; Huang, Chunye; Zhang, Zhanmin; Zhong, Hongguang; Zeng, Shaocheng; Shi, Qianqian; Xia, Yang; Zeng, Qinru; Wen, Qin; Chen, Jingyi; Dai, Xiaofeng; Xiong, Jianping; Xiang, Xiaojun; Lei, Wan; Deng, Jun

Identification of biomarkers related to immune and inflammation in membranous nephropathy: comprehensive bioinformatic analysis and validation.

膜性肾病中免疫和炎症相关生物标志物的鉴定:综合生物信息学分析和验证

Zhang Pingna, Geng Yunling, Tang Jingyi, Cao Zijing, Xiang Xiaojun, Yang Kezhen, Chen Hongbo

Bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trial

双功能抗PD-L1/TGF-βRII药物SHR-1701治疗晚期实体瘤:一项剂量递增、剂量扩展和临床扩展的1期试验

Liu, Dan; Zhou, Jun; Wang, Yongsheng; Li, Mingjun; Jiang, Haiping; Liu, Yunpeng; Yin, Xianli; Ge, Minghua; Xiang, Xiaojun; Ying, Jieer; Huang, Jian; Zhang, Yan-Qiao; Cheng, Ying; Huang, Zhigang; Yuan, Xianglin; Han, Weiqing; Yan, Dong; Wang, Xinshuai; Liu, Pan; Wang, Linna; Zhang, Xiaojing; Luo, Suxia; Liu, Tianshu; Shen, Lin

The E3 ubiquitin ligase, FBXW5, promotes the migration and invasion of gastric cancer through the dysregulation of the Hippo pathway

E3泛素连接酶FBXW5通过Hippo信号通路的失调促进胃癌细胞的迁移和侵袭。

Yao, Yangyang; Liu, Zhen; Huang, Shanshan; Huang, Chunye; Cao, Yuan; Li, Li; Guo, Hui; Liu, Fenfen; Huang, Shipeng; Liao, Quan; He, Xin; Chen, Jun; Li, Junhe; Xiang, Xiaojun; Xiong, Jianping; Deng, Jun